Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

Retractable Technologies stock opened at $0.92 on Friday. The company has a market cap of $27.47 million, a price-to-earnings ratio of -3.53 and a beta of 2.11. The business’s 50 day simple moving average is $1.10 and its 200 day simple moving average is $1.14. Retractable Technologies has a 12 month low of $0.87 and a 12 month high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The company had revenue of $7.60 million for the quarter.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw acquired 48,635 shares of Retractable Technologies stock in a transaction dated Thursday, May 16th. The shares were purchased at an average cost of $1.03 per share, with a total value of $50,094.05. Following the completion of the purchase, the chief executive officer now owns 14,417,148 shares of the company’s stock, valued at $14,849,662.44. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders have bought a total of 129,367 shares of company stock valued at $135,644 over the last 90 days. 54.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC increased its holdings in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the quarter. WealthTrust Axiom LLC owned approximately 0.42% of Retractable Technologies worth $151,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.